Table 2.
Retrospective and prospective studies used for this investigation
|
Patient characteristics |
Organ systems affected by associated NPL |
||||||||||||||||||
| Au-thor | Year | Date of diag-nosis | N |
Age average (median) |
Sex m/f |
Nu-mber (rate) of pati-ents with ass. NPL | GI-tract | Liver/ gall bla-dder/ pan-creas | Uro geni-tal tract | Fem-ale geni-tal tract | Bre-ast | Blo-od/ lymp-hatic sys-tem | Head and neck | Lung | Skin/ mela noma | Soft | Other | ||
| Total pop-ula-tion | Pat. with ass. NPL | Total pop-ula-tion | Pat. with ass. NPL | ||||||||||||||||
| Ad-im et al[137] | 2011 | 1997-2009 | 78 | 62 | 9/4 | 13 (17%) | 9 | 2 | 1 | 1 | |||||||||
| Aga-imy et al[14] | 2005 | 1997-2004 | 97 | 65 | 72 | 42/55 | 6/12 | 18 (17%) | 6 | 3 | 2 | 3 | 2 | 2 | 2 | ||||
| Agh-das-si et al[138] | 2018 | 1993-2011 | 104 | 67 | 54/50 | 44 (42%) | 16 | 4 | 8 | 7 | 2 | 1 | |||||||
| Am-aad-our et al[139] | 2013 | 1998-2006 | 43 | 62 | 65 | 15/28 | 1/5 | 6 (14%) | 5 | 1 | |||||||||
| Fer-nan-dez et al[140] | 2018 | 1999-2016 | 104 | 64 | 62/42 | 22/10 | 32 (31%) | 9 | 4 | 7 | 3 | 3 | 2 | 2 | 1 | 1 | |||
| Ferr-eira et al[141] | 2010 | 1998-2006 | 43 | 62 | 61 | 15/28 | 1/5 | 6 (14%) | 5 | 1 | |||||||||
| Giu-liani et al[142] | 2012 | 2002-2010 | 24 | 66 | 69 | 12/12 | 5/3 | 8 (33%) | 6 | 1 | 1 | ||||||||
| Gon-alves et al[143] | 2010 | 1998-2008 | 101 | 68 | 5/9 | 14 (14%) | 8 | 2 | 2 | 1 | 1 | ||||||||
| Hec-htm-ann et al[144] | 2015 | 2009-2013 | 260 | 65 | 142/118 | 30/20 | 50 (19%) | 2 | 21 | 1 | 8 | 8 | 7 | 1 | 3 | 3 | 6 | ||
| Kra-mer et al[17] | 2015 | 2006-2011 | 836 | 68 | 69 | 423/413 | 148/119 | 422 (51%) | 118 | 20 | 60 | 22 | 26 | 23 | 6 | 8 | 23 | 2 | 9 |
| Lai et al[145] | 2016 | 1995-2015 | 749 | 68 | 77/59 | 136 (18%) | 64 | 27 | 12 | 10 | 7 | 1 | 9 | 13 | 4 | 3 | 10 | ||
| Lis-zka et al[146] | 2007 | 1989-2006 | 82 | 64 | 38/44 | 12/10 | 22 (27%) | 17 | 5 | 1 | |||||||||
| Ma-yr et al[15] | 2019 | 1998-2017 | 188 | 69 | 70 (37%) | 23 | 1 | 17 | 9 | 5 | 5 | 2 | 5 | 3 | |||||
| Mur-phy et al[12] | 2015 | 2001-2011 | 6112 | 3252/2860 | 727/481 | 1047 (17%) | 208 | 34 | 432 | 144 | 80 | 54 | 99 | 52 | 48 | 72 | |||
| Pan-dur-eng-an et al[147] | 2010 | 1995-2007 | 783 | 57 | 444/339 | 91/62 | 153 (20%) | 40 | 8 | 48 | 14 | 15 | 12 | 1 | 10 | 9 | 9 | 20 | |
| Ponti et al[148] | 2010 | 1988-2007 | 141 | 66 | 67 | 77/64 | 20/26 | 46 (33%) | 18 | 1 | 7 | 2 | 6 | 1 | 2 | 1 | 2 | 3 | |
| Ric-hter et al[149] | 2008 | 1993-2005 | 54 | 65 | 28/26 | 13 (20%) | 7 | 3 | 1 | 1 | 1 | ||||||||
| Rod-riq-uenz et al[150] | 2016 | 2002-2014 | 128 | 65 | 68 | 59/69 | 19/27 | 46 (34%) | 24 | 5 | 3 | 4 | 2 | 1 | 1 | 3 | 3 | 1 | |
| Rub-io-Cas-ade-vall et al[151] | 2015 | 1996-2006 | 132 | 65 | 67/53 | 30 (23%) | 8 | 2 | 3 | 1 | 3 | 3 | |||||||
| Sevi-nc et al[152] | 2011 | 2002-2009 | 200 | 67 | 20/12 | 32 (16%) | 16 | 5 | 1 | 2 | 1 | 2 | 1 | 4 | |||||
| Smi-th et al[13] | 2016 | 2001-2009 | 1705 | 63 | 69 | 885/820 | 95/86 | 181 (11%) | |||||||||||
| Vas-sos et al[153] | 2014 | 2000-2009 | 86 | 66 | 70 | 50/36 | 27/10 | 37 (43%) | 19 | 7 | 5 | 4 | 3 | 3 | 1 | ||||
| 12050 | 63 | 68 | 1.1 : 1 | 1.4 : 1 | 2426 (20,1%) | 751 (32%) | 706 (30%) | 236 (10%) | 145 (6%) | 85 (4%) | 145 (6%) | 101 (4%) | 74 (3%) | 130 (5%) | |||||